TY - JOUR
T1 - Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9
AU - Fu, Yongyao
AU - Pajulas, Abigail
AU - Wang, Jocelyn
AU - Zhou, Baohua
AU - Cannon, Anthony
AU - Cheung, Cherry Cheuk Lam
AU - Zhang, Jilu
AU - Zhou, Huaxin
AU - Fisher, Amanda Jo
AU - Omstead, David T.
AU - Khan, Sabrina
AU - Han, Lei
AU - Renauld, Jean Christophe
AU - Paczesny, Sophie
AU - Gao, Hongyu
AU - Liu, Yunlong
AU - Yang, Lei
AU - Tighe, Robert M.
AU - Licona-Limón, Paula
AU - Flavell, Richard A.
AU - Takatsuka, Shogo
AU - Kitamura, Daisuke
AU - Sun, Jie
AU - Bilgicer, Basar
AU - Sears, Catherine R.
AU - Yang, Kai
AU - Kaplan, Mark H.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Although IL-9 has potent anti-tumor activity in adoptive cell transfer therapy, some models suggest that it can promote tumor growth. Here, we show that IL-9 signaling is associated with poor outcomes in patients with various forms of lung cancer, and is required for lung tumor growth in multiple mouse models. CD4+ T cell-derived IL-9 promotes the expansion of both CD11c+ and CD11c− interstitial macrophage populations in lung tumor models. Mechanistically, the IL-9/macrophage axis requires arginase 1 (Arg1) to mediate tumor growth. Indeed, adoptive transfer of Arg1+ but not Arg1- lung macrophages to Il9r−/− mice promotes tumor growth. Moreover, targeting IL-9 signaling using macrophage-specific nanoparticles restricts lung tumor growth in mice. Lastly, elevated expression of IL-9R and Arg1 in tumor lesions is associated with poor prognosis in lung cancer patients. Thus, our study suggests the IL-9/macrophage/Arg1 axis is a potential therapeutic target for lung cancer therapy.
AB - Although IL-9 has potent anti-tumor activity in adoptive cell transfer therapy, some models suggest that it can promote tumor growth. Here, we show that IL-9 signaling is associated with poor outcomes in patients with various forms of lung cancer, and is required for lung tumor growth in multiple mouse models. CD4+ T cell-derived IL-9 promotes the expansion of both CD11c+ and CD11c− interstitial macrophage populations in lung tumor models. Mechanistically, the IL-9/macrophage axis requires arginase 1 (Arg1) to mediate tumor growth. Indeed, adoptive transfer of Arg1+ but not Arg1- lung macrophages to Il9r−/− mice promotes tumor growth. Moreover, targeting IL-9 signaling using macrophage-specific nanoparticles restricts lung tumor growth in mice. Lastly, elevated expression of IL-9R and Arg1 in tumor lesions is associated with poor prognosis in lung cancer patients. Thus, our study suggests the IL-9/macrophage/Arg1 axis is a potential therapeutic target for lung cancer therapy.
UR - http://www.scopus.com/inward/record.url?scp=85133342859&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133342859&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-31596-7
DO - 10.1038/s41467-022-31596-7
M3 - Article
C2 - 35778404
AN - SCOPUS:85133342859
SN - 2041-1723
VL - 13
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 3811
ER -